(1-Ethyl-1H-pyrazol-5-yl)boronic acid

Catalog No.: 
ACQYIP604
CAS No.: 
1095080-54-8
Molecular Formula: 
C5H9BN2O2
Molecular Weight: 
139.95
(1-Ethyl-1H-pyrazol-5-yl)boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$101.00In stockInquiry
25g97%$500.00InquiryInquiry
100g97%$1960.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1-Ethyl-1H-pyrazol-5-yl)boronic acid
IUPAC Name(1-ethyl-1H-pyrazol-5-yl)boronic acid
MDL No.MFCD03419491
Molecular FormulaC5H9BN2O2
Molecular Weight139.95
SMILESCCN1N=CC=C1B(O)O
InChI KeyZMKALWZRSCXBEY-UHFFFAOYSA-N
Synonym1-Ethylpyrazole-5-boronic Acid;(1-Ethyl-1H-pyrazol-5-yl)boronic acid;B-(1-Ethyl-1H-pyrazol-5-yl)boronic acid;(1-ETHYL-1H-PYRAZOL-5-YL)BORANEDIOL;Boronic acid, B-(1-ethyl-1H-pyrazol-5-yl)-;(1-Ethyl-1H-pyrazol-5-yl)boronic acid - [E16540]
CAS No.1095080-54-8
PubChem CID49964170

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACQYIP604 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLSJF082 route compound structure diagram
    ACLSJF0821310383-92-6In Stock
  4. Then
  5. ACQYIP604 route product structure diagram
    ACQYIP6041095080-54-8In Stock
Inquiry

2. ACQYIP604 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSCZU760 route compound structure diagram
    ACSCZU7601007110-53-3In Stock
  2. Then
  3. ACQYIP604 route product structure diagram
    ACQYIP6041095080-54-8In Stock
Inquiry

3. ACQYIP604 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQYIP604 route product structure diagram
    ACQYIP6041095080-54-8In Stock
Inquiry

Comments (0)